n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid has been researched along with thymidine in 1 studies
| Studies (n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid) | Trials (n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid) | Recent Studies (post-2010) (n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid) | Studies (thymidine) | Trials (thymidine) | Recent Studies (post-2010) (thymidine) |
|---|---|---|---|---|---|
| 40 | 0 | 7 | 33,410 | 241 | 1,117 |
| Protein | Taxonomy | n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid (IC50) | thymidine (IC50) |
|---|---|---|---|
| Thymidine kinase | Macacine alphaherpesvirus 1 | 4.1 | |
| Thymidine kinase, cytosolic | Homo sapiens (human) | 0.614 | |
| Thymidine kinase | Human alphaherpesvirus 1 strain SC16 | 1 | |
| Sterol O-acyltransferase 1 | Cricetulus griseus (Chinese hamster) | 1.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbas Rizvi, SM; Allen, BJ; Goozee, G; Sarkar, S | 1 |
1 other study(ies) available for n-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1,2-diamine-n,n',n',n'',n''-pentaacetic acid and thymidine
| Article | Year |
|---|---|
Radioimmunoconjugates for targeted alpha therapy of malignant melanoma.
Topics: Antibodies, Monoclonal; Bismuth; Chelating Agents; DNA, Neoplasm; Humans; Immunoconjugates; Isothiocyanates; Melanoma; Nucleic Acid Synthesis Inhibitors; Pentetic Acid; Radioisotopes; Terbium; Thymidine; Time Factors; Tumor Cells, Cultured | 2000 |